Replies to post #590062 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

thanks.
well. Its not only adding a few positions. Its adding hundreds of them in an already very tight labor market. Novocure has 1,167 employees, and Kite Pharma had 700 before they were bought. Just bought Prometheus Biosciences total number of employees in 2022 was 97.
If you would add the number of staff working at Advent(54) to NWBO (15) we are looking at 69 in total (I personally believe Merck will buy Advent together with NWBO).

Look at how long it took Advent to add 54 people to its staff. If NWBO would want to stay independent it would take many years after approval to get to a team of at least 600-700 needed to become some form of mid-independent large biotech. They really should have started building a team, on thin finances, 2 years ago.

but I'd be curious to know if NWBO, at this point in time, hired for any of the positions that would be needed to stay as an independent company.

I have not seen any on LinkedIn or anywhere else.

The correct way would be for Advent to release drug to the Sponsor and Sponsor release drug to market (i.e. no conflict of interest).

Exactly. Advent did hire one staff as a patient liaison. I think that for the rising demand for compassionate use.